논문KCI 등재
Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (11)
관련 논문AI추천
Reappraisal of transarterial radioembolization for liver-confined hepatocellular carcinoma with portal vein tumor thrombosis: Editorial on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”Dong Il Gwon, Gun Ha Kim, Jin Hyoung Kim대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosisHang Li, Hua Lu, Xiao-Song Li, Xi-Ping Shen대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: ReplyAhn Young Eun, Jung Young Kul, Kim Tae Hyung, Yim Hyung Joon거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제2호Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisDeng Min, Guo Rongping, Li Shaohua, Wei Wei거트앤리버 소화기연관학회협의회 · Gut and Liver2023 · 제17권 제2호Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis김경민, 김도영, Dongho Hyun, Dong Hyun Sinn, Han Ah Lee, Hyo-Cheol Kim, In Joon Lee, Jae Seung Lee, Joong-Won Park, Moon Haeng Hur, Yeon Seok Seo, Yoon Jun Kim, Yuri Cho대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”Dong Yun Kim, Do Young Kim, Hong Jae Chon, Young Eun Chon대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호
이 간행물의 다른 논문 (84건)
Roles of X-box binding protein 1 in liver pathogenesisYun Seok Kim, Jihoon Tak, Sang Geon Kimpp. 1-31Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screeningTian Xia, Jiawen Wangpp. 1-2KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025Eun Joo Lee, Jung Hee Kim, Byoung Kuk Jang, Miyoung Choi, Su Jong Yu, Young-Sun Lee, Young-Joo Jin, Hye Won Lee, Soon Sun Kim, Pil Soo Sung, Young Kul Jung, Gi-Ae Kim, Young Chang, Won Sohn, Jeong-ju Yoopp. 1-31Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosisHua Lu, Xiao-Song Li, Xi-Ping Shen, Hang Lipp. 3-4Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adultsDonghee Kim, Aijaz Ahmed, Won Kimpp. 5-7